Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Yoshihiro Yamamoto is active.

Publication


Featured researches published by Yoshihiro Yamamoto.


Cancer Immunology, Immunotherapy | 2000

Antitumor effect of heat-killed Lactobacillus plantarum L-137 through restoration of impaired interleukin-12 production in tumor-bearing mice

Shinji Murosaki; Koutarou Muroyama; Yoshihiro Yamamoto; Yasunobu Yoshikai

Abstractu2002We have previously reported that heat-killed Lactobacillus plantarum L-137 is a potent inducer of interleukin-12 (IL-12) inu2009vivo as well as inu2009vitro in mice. In order to develop effective usage of L. plantarum L-137 for tumor immunotherapy, we examined its antitumor effect against DBA/2 mice inoculated with syngenic P388D1 tumor cells in different treatment schedules. Daily injection of L. plantarum L-137 from the day of tumor inoculation induced a steep increase in plasma IL-12 only after the first injection but not after subsequent injections, and had no effect on tumor growth and survival time. In contrast, daily injection of L. plantarum L-137 from the 7th day after tumor inoculation exerted a marked antitumor effect but such an effect was not evident in mice treated with L. plantarum L-137 twice a week from the 7th day. IL-12 production was considerably impaired at the first injection but steeply increased after the third injection in the mice injected daily with L. plantarum L-137 from the 7th day. Our results suggest that daily administration of L. plantarum L-137 is required to exert an antitumor effect at the late stages of tumor development when IL-12 production is considerably impaired.


International Immunopharmacology | 2002

Nigerooligosaccharides augments natural killer activity of hepatic mononuclear cells in mice

Shinji Murosaki; Koutarou Muroyama; Yoshihiro Yamamoto; Tiei Liu; Yasunobu Yoshikai

Nigerooligosaccharides (NOS), a mixture of nigerose and nigerosylmaltooligosaccharides, is immunopotentiating oligosaccharides found in foodstuffs. Augmentation of natural killer (NK) activity by NOS was studied in vitro and in vivo in mice. In vitro treatment of hepatic mononuclear cells (MNC) from normal mice with 1 micro/ml NOS 17 h or just prior to the cytotoxicity assay enhanced their cytotoxicity against YAC-1 cells. NK activity of hepatic MNC was also enhanced in mice injected intraperitoneally with 0.4 mg NOS or in mice given 1% NOS solution orally as a drinking fluid. In association with the augmentation of NK activity, increase in the liver weight induced by intravenous inoculation of EL-4 tumor cells was significantly suppressed by intraperitoneal pretreatment with 0.4 mg NOS. Moreover, drinking 1% NOS significantly improved the survival curve of mice intravenously inoculated with EL-4 cells. Our results suggest that the immunopotentiating activity of NOS is exerted partly through the augmentation of NK activity.


Bioscience, Biotechnology, and Biochemistry | 2003

Effects of Intake of a Mixture of Thiamin, Arginine, Caffeine, and Citric Acid on Adiposity in Healthy Subjects with High Percent Body Fat

Koutarou Muroyama; Shinji Murosaki; Yoshihiro Yamamoto; Akitoshi Ishijima; Yasuo Toh

We assessed the effects of intake of thiamin, arginine, caffeine, and citric acid (TACC) on lipid metabolism in healthy subjects. Thirty-one subjects with high percent body fat (≥25.0%) were randomly assigned to a 12-wk intervention with daily intake of TACC-supplemented tea (1.1, 1240, 52, and 540 mg, respectively; n=16) or control tea (n=15). The percent body fat decreased significantly during the intervention in both groups, especially in the TACC group. A percentage decrease in triceps skinfold was significantly greater in the TACC group than in the control group. The decrease in abdominal visceral fat in obese subjects was significantly greater in the TACC group than in the control group. Serum triglyceride was significantly lower during intervention than that during the non-intervention period in the TACC group. These results suggest that TACC may be effective in reducing body fat in obese subjects.


Immunopharmacology and Immunotoxicology | 2004

Nigerooligosaccharides augments mitogen-induced proliferation and suppresses activation-induced apoptosis of human peripheral blood mononuclear cells.

Yoshitaka Hirose; Shinji Murosaki; Yoshihiro Yamamoto; Hideyuki Ikematsu; Kikuo Nomoto

Nigerooligosaccharides (NOS), a mixture of nigerose and nigerosylmaltooligosaccharides, consists of immunopotentiating oligosaccharides found in foodstuffs. We have previously reported that activation of peripheral blood mononuclear cells (PBMC) in response to concanavalin A (Con A) or a streptococcal preparation of OK‐432 is augmented in healthy young adults and elderly subjects after the intake of NOS‐supplemented syrup. A reappraisal of the data suggests that NOS augments proliferation but partly suppresses activation‐induced apoptosis of PBMC in response to these mitogens. To confirm this hypothesis, PBMC from healthy male subjects were stimulated with Con A or OK‐432 in the presence of nigerose at the concentrations at which it was detected in the blood of subjects who had ingested NOS‐supplemented syrup. Cellular activation, specifically metabolic demand, viability and proliferation, was assessed from glucose consumption, by WST‐1 colorimetry and by 5‐bromo‐2′‐deoxy‐uridine incorporation assay, respectively. The Con A‐induced activation of PBMC in each measurement was significantly augmented by nigerose. OK‐432‐induced decreases in the viability of PBMC were significantly inhibited by nigerose. Stimulation of PBMC with Con A or OK‐432 induced apoptosis, but nigerose suppressed such activation‐induced cell death. These results indicated that nigerose activated PBMC in vitro in a manner similar to the process observed in vivo, providing further evidence for the effectiveness of consumption of NOS‐supplemented syrup.


Analytical Biochemistry | 2016

Fatty acid analysis of triacylglycerols: Preparation of fatty acid methyl esters for gas chromatography

Ken'ichi Ichihara; Chihiro Kohsaka; Naohiro Tomari; Tamami Kiyono; Jun Wada; Kiyoo Hirooka; Yoshihiro Yamamoto

A method to prepare fatty acid methyl esters was developed for fatty acid analysis of triacylglycerols by gas chromatography (GC). Triacylglycerols were mixed with methanolic CH3ONa in hexane containing a mid-polar solvent for 10xa0s at room temperature. Under these conditions, trioleoylglycerol was converted to methyl oleate with an average yield of 99.3%. This procedure gave reliable and reproducible data on fatty acid compositions determined by GC.


Bioscience, Biotechnology, and Biochemistry | 1999

Immunopotentiating activity of nigerooligosaccharides for the T helper 1-like immune response in mice.

Shinji Murosaki; Koutarou Muroyama; Yoshihiro Yamamoto; Hiroaki Kusaka; Tiei Liu; Yasunobu Yoshikai


Analytical Biochemistry | 2006

A nonradioisotope, enzymatic assay for 2-deoxyglucose uptake in L6 skeletal muscle cells cultured in a 96-well microplate

Norio Yamamoto; Takuya Sato; Kengo Kawasaki; Shinji Murosaki; Yoshihiro Yamamoto


Archive | 1994

Process for producing proteinaceous microparticles

Norio Yamamoto; Yoshihiro Yamamoto; Tetsuo Nunome; Koutarou Muroyama; Hiroaki Kusaka


Archive | 1997

Proteinaceous microparticles and production thereof

Norio Yamamoto; Yoshihiro Yamamoto; Akihiro Tani; Seiichi Nakano; Hiroaki Kusaka


Japanese Journal of Physiological Anthropology | 2000

EFFECTS OF ADDITIVE FLAVOR ON PHYSIOLOGICAL RESPONSE ACCOMPANIED WITH TEA INGESTION

Kuniko Yamashita; Yoshiaki Sone; Yuko Tsuruoka; Yoshihiro Yamamoto

Collaboration


Dive into the Yoshihiro Yamamoto's collaboration.

Top Co-Authors

Avatar

Shinji Murosaki

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Koutarou Muroyama

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Hiroaki Kusaka

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Norio Yamamoto

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Naohiro Tomari

Industrial Research Institute

View shared research outputs
Top Co-Authors

Avatar

Akihiro Tani

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Akitoshi Ishijima

Takeda Pharmaceutical Company

View shared research outputs
Researchain Logo
Decentralizing Knowledge